Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Rise of Generics and Patent Expirations Sees CPhI and P-MEC India 2013 Expand

Published: Tuesday, December 03, 2013
Last Updated: Monday, December 02, 2013
Bookmark and Share
Free online registration to attend CPhI and P-MEC India is now closed.

CPhI has announced that CPhI and P-MEC India, ran by leading events organizer UBM, is returning to the Bombay Convention and Exhibition Centre, Mumbai (India) from the 3rd to the 5th December 2013.

The event will return with an increased scale, continuing its commitment to cater to all sectors of the pharma industry by co-locating with ICSE and BioPh India.

With a view to enhancing the customer experience and ROI value, CPhI India has enhanced the mobile application, now available on all mobile devices with an internet connection, designed to help attendees navigate their way around the event, drive traffic to stands and stay up to date with schedules and speaker events.

With the addition of hall 7, P-MEC will host even more exhibitors than previous years. Last year, there were 926 exhibitors present and this is expected to rise to 1,000 this year to create the biggest show to date.

Free online registration to attend CPhI and P-MEC India is now closed, however registration is still possible in Mumbai, the onsite fee is only INR500.

India has increasingly become a focal point of the pharmaceutical industry and is now the third largest in terms of volume. The country is fast becoming an innovation hub, increasingly matching Western standards, whilst also reducing the costs of manufacturing, showcasing the Indian pharma markets unique position and providing an optimum investment platform for international companies.

Outside of the US, India has the highest number of FDA approved facilities (546), and the Indian pharma sector received USFDA approvals for around 40% of all Abbreviated New Drug Approvals (ANDA) during January-July 2013.

Further, with R&D investments rapidly advancing, coupled with the rise in generics and supergenerics, India represents a key maturing market, with CPhI and P-MEC India facilitating opportunities to drive and enhance the sector.

Ahead of the event, the UBM India pharma awards will take place on 2nd December, celebrating the most innovative and dynamic areas across the Indian pharma community.

Honouring companies who are driving forward industry changing initiatives, there will be awards for multiple categories including ‘Excellence in Product Development’, ‘Excellence in Contract Research’ and ‘Excellence in Packaging Development’.

The evening will also host a panel discussion on ‘Moving up the Global Pharma Value Chain’, designed to inform and educate those present at the awards ceremony.

“The global pharmaceutical market has seen a significant shift over the last year, particularly as patent expirations are becoming more frequent and a potential patent cliff is shaking the industry. India, however, is thriving as the demand for generics is on the rise and companies are looking to drive down manufacturing costs. India is well positioned to accommodate increased demand, providing expertise in development and manufacturing. CPhI and P-MEC India will provide the ideal and essential platform for international and domestic suppliers and buyers to break into the market,” Chris Kilbee, Group Director, Pharma.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More Than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Experts Analyse Growth in the Finished Dosage Market
New drug delivery and bioavailability technology driving growth globally.
Tuesday, June 07, 2016
Demand for International Pharma Manufacturers and Ingredients Increasing in Russia
CPhI Russia 2016 opens as the country is seeking rapid upgrades to GMP standards.
Wednesday, February 24, 2016
CPhI Worldwide Introduce New Event
Expanding its reputation as a global hub for the final dose supply chain is a key strategy for CPhI in 2016.
Wednesday, February 17, 2016
CPhI Worldwide Launches Pharma Insights 2016 USA Report at InformEx 2016
CPhI report warns international manufacturers about the need to invest in domestic US sites and indicates that US CDMOs are well placed to keep biosimilars development work into commercialisation.
Friday, February 05, 2016
CPhI Worldwide Closes with Growth Forecast in FDI and Latin American Exports
Event sees record exhibitor attendance and is set to return to thriving Spain in 2016.
Friday, December 18, 2015
CPhI Report Highlights Acquisitions of Niche Technologies
Medium term prospects for contract services remain positive (both developed and emerging markets), despite fragmented biosimilar regulation and GDUFA fees.
Thursday, October 15, 2015
#CPhIChat Returns to CPhI Worldwide for the Second Successive Year
Pharma community is encouraged to lend their views on key industry issues.
Saturday, October 10, 2015
CPhI Experts Predict Continuous Manufacturing for All Within 10-years
Brian Carlin emphasizes need to build flexibility into design to manage impact of raw material variability through product lifecycle.
Thursday, October 01, 2015
CPhI China Report Predicts Domestic Growth to Outpace Exports
Emerging cities, biopharmaceuticals and APIs to drive future expansion.
Friday, August 14, 2015
CPhI & P-MEC China Closes as the Chinese Domestic Market Continues to Expand
International companies looking to gain a foothold in this lucrative and gentrifying pharma economy.
Tuesday, August 11, 2015
CPhI Korea Opens as South Korea Emerges as Global Leader in Biosimilar Trials
Government’s R&D strategy and “Pharma 2020 Vision” to see country as drug development leader.
Monday, July 27, 2015
CPhI Announces USA Market Report at InformEx
Country report to contain contrasting insights into the American pharma economy from European and domestic perspectives.
Wednesday, January 22, 2014
Chris Kilbee Appointed Group Director of UBM Pharma Portfolio
Kilbee responsible for driving the portfolio globally including increased emphasis on digital and content.
Monday, January 13, 2014
CPhI Japan 2014: Japanese Market to Continue to Dominate Global Pharma
Growth in the World’s second largest pharma region facilitated by innovation and loosened regulatory guidelines.
Monday, December 30, 2013
John van der Valk Appointed MD of UBM Live Amsterdam
Valk responsible for overseeing the company’s flagship brand CPhI.
Monday, December 23, 2013
Scientific News
Shedding Light on HIV Vaccine Design
Broadly speaking - Mathematical modelling of host-pathogen coevolution sheds light on HIV vaccine design.
AACC 2016 Sees Clinical Chemistry Labs Drive Precision Medicine Offerings
Biomarker assays to enable precision medicine and risk assessment, mass spec-based tests designed for use in clinical labs large and small, and liquid biopsy technology captured the spotlight at the AACC annual meeting.
Automated Patch Clamping Trends
Learn more about current practices, preferences and metrics in ion channel drug screening using APC technology.
Lab-on-a-Stick: Miniaturised Clinical Testing For Fast Detection Of Antibiotic Resistance
A portable power-free test for the rapid detection of bacterial resistance to antibiotics has been developed by academics at Loughborough University and the University of Reading.
Genetic Ancestry of Cultivated Strawberry Unravelled
UNH scientists constructed a linkage map of the seven chromosomes of the diploid Fragaria iinumae, which allows them to fill in a piece of the genetic puzzle about the eight sets of chromosomes of the cultivated strawberry.
Progress In Vaccination Against Vespid Venom
Researchers at the Helmholtz Zentrum München and the Technical University Munich have presented a method which facilitates a personalised procedure for wasp allergy sufferers.
New Drug Target for Inflammatory Disorders
Penn study finds enigmatic molecules maintain equilibrium between fighting infection and inflammatory havoc.
Breast Cancer Cells Found To Switch Molecular Characteristics
Spontaneous interconversion between HER2-positive and HER2-negative states could contribute to progression, treatment resistance in breast cancer.
Mechanisms of Calcium Blockers
Researchers describe how the fundamental mode of action of two distinct chemical classes of calcium channel blockers differs.
Some Breast Cancer Patients With Low Genetic Risk Could Skip Chemotherapy
Genetic test can help predict survival and guide treatment options.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!